%D8%AF%D8%A7%D9%83%D8%AA%D9%8A%D9%86%D9%88%D9%85%D8%A7%D9%8A%D8%B3%D9%8A%D9%86%D8%AF%D8%A7%DA%A9%D8%AA%DB%8C%D9%86%D9%88%D9%85%D8%A7%DB%8C%D8%B3%DB%8C%D9%86Category:DactinomycinDactinomycinActinomycin_DDactinomycinActinomicina%D8%AF%D8%A7%DA%A9%D8%AA%DB%8C%D9%86%D9%88%D9%85%D8%A7%DB%8C%D8%B3%DB%8C%D9%86DaktinomysiiniActinomycine_D%E3%82%A2%E3%82%AF%E3%83%81%E3%83%8E%E3%83%9E%E3%82%A4%E3%82%B7%E3%83%B3%D0%90%D0%BA%D1%82%D0%B8%D0%BD%D0%BE%D0%BC%D0%B8%D1%86%D0%B8%D0%BD_%D0%94%EC%95%85%ED%8B%B0%EB%85%B8%EB%A7%88%EC%9D%B4%EC%8B%A0%E0%AC%A1%E0%AC%BE%E0%AC%95%E0%AD%8D%E0%AC%9F%E0%AC%BF%E0%AC%A8%E0%AD%8B%E0%AC%AE%E0%AC%BE%E0%AC%87%E0%AC%B8%E0%AC%BF%E0%AC%A8DaktynomycynaDactinomicin%C4%83%D0%94%D0%B0%D0%BA%D1%82%D0%B8%D0%BD%D0%BE%D0%BC%D0%B8%D1%86%D0%B8%D0%BDAktinomicinDaktinomicinAktinomicin%D0%90%D0%BA%D1%82%D0%B8%D0%BD%D0%BE%D0%BC%D1%96%D1%86%D0%B8%D0%BDDactinomycinQ186127%E6%94%BE%E7%BA%BF%E8%8F%8C%E7%B4%A0
about
sameAs
P3781
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk RhabdomyosarcomaA Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With CancerInternational Pleuropulmonary Blastoma (PPB) Treatment and Biology RegistryChemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' TumorChemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RTIsolated Limb Infusion Chemotherapy With Targeted Gene Therapy for Advanced, Unresectable Extremity MelanomaClinical Trial for Patients With a Stage IV Childhood Renal Tumor, Comparing Upfront Vincristine, Actinomycin-D and Doxorubicin (Standard Arm) With Upfront Vincristine, Carboplatin and Etoposide (Experimental Arm)Combination Therapy of Anthracyclines for Children With NephroblastomaCombination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma (GTN) Patients With Score of 5-6Evaluating Dactinomycin and Vincristine in Young Patients With CancerTemozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic RhabdomyosarcomaIntercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus TumorsCombination Chemotherapy and Surgery in Treating Young Patients With Wilms TumorDactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic NeoplasiaEfficacy of Dose Intensification in Patients With Non-metastatic Ewing SarcomaMethotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic NeoplasiaAddition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Melanoma of The ExtremityPhase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's SarcomaCombination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed RhabdomyosarcomaHigh-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or EctomesenchymomaVincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' TumorCombination Chemotherapy in Treating Young Patients With Nonmetastatic RhabdomyosarcomaCombination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' TumorCombination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney TumorsVincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal RhabdomyosarcomaVincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal RhabdomyosarcomaCombination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell TumorsCombination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's SarcomaSurgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood FibrosarcomaVincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk RhabdomyosarcomaCombination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal TumorsChemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the KidneyCombination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's SarcomaChemotherapy Before and After Surgery in Treating Children With Wilm's TumorIsolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By SurgeryCombination Chemotherapy in Treating Patients With Previously Untreated RhabdomyosarcomaCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or SarcomaMethotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic NeoplasiaDactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic NeoplasiaCombination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
P4844
Q1076481-B5306477-40FF-414E-A91B-9B08795BC292Q1138580-7FA6B37B-56A8-4287-98D3-0AE6D7EADFC7Q1138580-B17BA507-662F-4BB2-B8BA-57B2588B64C4Q1209744-4D6C8549-CA6F-4F99-BA0C-280BD1C91D93Q180614-DE3C96BB-2B05-409E-AB36-04444E23D568Q18553680-508B7439-7AD8-4E8E-B5A0-B84D2C66A099Q18556194-9E5224F9-3A10-4149-A7C5-4C28F4C19F4BQ18556413-A77D60F4-F79D-4080-BF64-B853DE9E3C9EQ1898141-B74D973C-909C-4FB6-8332-35E67E0342B1Q324464-D9158825-0F10-436F-9970-B9A94A3BCB3FQ725345-7892F227-96E9-4277-ACF6-CC754FEF2D8FQ881855-4E240A49-DEE9-4AAB-91BF-0B5C0C6BC858Q938205-23038A1E-80E6-4106-AD81-559F054FC34B
P2176
Q61862239-ACBF650C-8DFE-41CD-9478-B5FAD16819D0Q61917923-8AA81EBA-432E-4B90-A535-27ECBE5596FEQ61956704-44716C83-DF80-402F-911F-CE8B267F27A6Q62110374-AE93FA6F-81DB-4081-A9CB-34B34EC38525Q62110722-36C469D9-051C-40BC-A8D5-B8218A9B3346Q63316812-5080DA33-491B-4023-9633-A31C61EB3DA3Q63392857-2F562003-0C22-47B2-A87F-860088301449Q63580220-CA60604A-62E5-4AF1-8654-3C369D71B403Q63581827-AFD99629-7893-4566-8629-F275A05B532CQ64046770-EC24DE83-A376-4EFA-9AB7-CD7F65539D8EQ64656748-0F14875F-CC72-4302-8B0A-3B2D1961839DQ64659372-534EEDBD-84DB-4024-88AE-580349FB5472Q64665472-C870E5D8-72E1-40D8-B763-6368B4058217Q64672458-83309071-6530-47CD-978B-6A12881018C2Q65359390-944D0311-2700-438E-B537-FAECB59854A6Q65370308-405655E4-C395-4978-B58E-4683C33A56C1Q65376851-9A834215-66AF-41EC-8FA8-224A4EF7084AQ65380171-01980EB8-103F-4250-A88F-016B12A3E13EQ65387220-F7B0D39C-A7BE-4003-932B-6C9A2A97948BQ65387236-2487B43A-7B52-4D7D-9D34-0E51FCA63B4FQ65387637-2B1E558C-B455-4DD6-BCAC-C33EF8E39E9FQ65388357-9146B6B4-765E-4A6E-B1D8-934A5CCD077AQ65388393-03E46FF8-F825-472A-9239-CB213B721B10Q65389986-D266BE35-97F7-40E0-8AFE-479CD93301B4Q65542196-B5B3D5E2-CDD7-4CD6-9DBE-91DB951EF2F5Q65542202-2AF4B961-261C-4B99-8675-6C31C015E22EQ66032897-78A9C083-5647-4665-A215-7D67966C6F04Q66033404-FA0019B3-9F60-49D1-B80B-D9BBFB929751Q66034201-12A896AE-96D7-473B-A004-CC43D829835FQ66035644-73FFAF8D-B976-4560-BDFE-83500EE8DE76Q66036638-A3960358-B1A7-457E-A2CE-26C1B315BBC6Q66036682-9ED05410-9637-43C3-A113-F5665381DB98Q66036913-1B2BAA85-8A54-47C7-B0AC-FA1D323F491AQ66037788-24FE255A-4F48-4A61-8A4F-E0BCB5596C5CQ66037797-E89948C6-7C90-459C-BD32-5B739FC3085AQ66037926-FCF7C001-3C0A-4469-825E-9C72F1B8ABB6Q66037927-3DF69786-D3CB-4001-B27A-49DF49FCD232Q66038010-29092CFE-12B8-4641-A8A8-37FCA6B165ACQ66038017-C61464F9-C1CF-4789-ABB4-26F779DF9F9FQ66038372-2040BFC4-0ED4-461A-87F3-B2B0E0D66E1B
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Actinomicina
@es
Actinomycin D
@de
Aktinomicin
@sh
Aktinomicin
@sr
Dactinomicină
@ro
Dactinomycin
@vi
Daktinomicin
@sl
Daktinomysiini
@fi
actinomycine D
@fr
dactinomicina
@pt
type
label
Actinomicina
@es
Actinomycin D
@de
Aktinomicin
@sh
Aktinomicin
@sr
Dactinomicină
@ro
Dactinomycin
@vi
Daktinomicin
@sl
Daktinomysiini
@fi
actinomycine D
@fr
dactinomicina
@pt
altLabel
2-amino-N,N'-bis(hexadecahydro ...... -phenoxazine-1,9-dicarboxamide
@en
ActD
@en
Actinomycin C1
@en
Actinomycin D 或 Dactinomycin
@cy
Actinomycin D 或 Dactinomycin
@en
Actinomycin D
@en
Actinomycin iv
@cy
Actinomycin iv
@en
Cosmegen
@cy
Cosmegen
@en
prefLabel
Actinomicina
@es
Actinomycin D
@de
Aktinomicin
@sh
Aktinomicin
@sr
Dactinomicină
@ro
Dactinomycin
@vi
Daktinomicin
@sl
Daktinomysiini
@fi
actinomycine D
@fr
dactinomicina
@pt